Increased levels of human myeloperxidase (MPO) and neutrophil lipocalin (HNL/NGAL) in childhood asthma

C. Kim (Seoul, Republic of Korea), D. Shim (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), H. Cha (Seoul, Republic of Korea), S. Hwang (Seoul, Republic of Korea), J. Park (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), M. Sohn (Seoul, Republic of Korea)

Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Session: Understanding, monitoring and targeting severe asthma
Session type: Poster Discussion
Number: 530
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Kim (Seoul, Republic of Korea), D. Shim (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), H. Cha (Seoul, Republic of Korea), S. Hwang (Seoul, Republic of Korea), J. Park (Seoul, Republic of Korea), K. Kim (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), M. Sohn (Seoul, Republic of Korea). Increased levels of human myeloperxidase (MPO) and neutrophil lipocalin (HNL/NGAL) in childhood asthma. 530

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease
Year: 2003


Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF
Source: ERS Lung Science Conference 2021
Year: 2021

Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD
Source: Annual Congress 2003 - From gene to breath analysis in airway disorders
Year: 2003


Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation
Source: Eur Respir J 2003; 22: 739-742
Year: 2003



Circadian variations in serum eosinophil cationic protein (ECP), and serum and urine eosinophil protein X (EPX) in children
Source: Eur Respir J 2001; 18: Suppl. 33, 451s
Year: 2001

Relationship between interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reaktive protein (CRP), albumin (ALB) and alkaline phosphatase (ALP) in bronchoalveolar lavage fluid (BALF) of patients with interstitial lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006

Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


The effect of sputum processing on tumour necrosis factor (TNFα), secretory leukoprotease inhibitor (SLPI), interleukin-6 and leukotriene-B4 (LTB4) in chronic bronchitis and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 364s
Year: 2001

Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
Source: Eur Respir J 2015; 45: 1482-1485
Year: 2015


Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009


Influence of moderate altitude and endurance challenge on serum eosinophil cationic protein (ECP), eosinophil dynamics and lung function
Source: Eur Respir J 2001; 18: Suppl. 33, 368s
Year: 2001

Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP)
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


PDK1/RSK1-dependent C/EBPß activation is involved in thrombin-induced expression of orosomucoid 1-like 3 (ORMDL3) and IL-8/CXCL8 in human lung epithelial cells
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum
Source: Eur Respir J 2002; 20: Suppl. 38, 143s
Year: 2002